Le Lézard
Classified in: Health
Subject: POL

As Screen Time Reaches All-Time Highs, California Recognizes the 3rd Annual Blue Light Awareness Day on October 10


MINNEAPOLIS, Oct. 7, 2021 /PRNewswire/ -- In 2019, Senator Richard Pan and the California legislature passed the California State Resolution SCR-73, designating October 10 as 'Blue Light Awareness Day' and encouraging citizens to take proactive safety measures in reducing eye exposure to high-energy visible blue light from digital devices, such as smartphones, laptops, monitors and tablets. This resolution reflected the large and growing body of research from the scientific community, which identifies numerous known and emerging health concerns for all age groups due to blue light exposure, including impacts on circadian rhythm and melatonin release, digital eye strain, headaches and cognitive performance.

Starting on Sunday to commemorate the 3rd annual Blue Light Awareness Day in California, California Senator Dr. Richard Pan, along with Eyesafe, UnitedHealthcare, and ZAGG, are collaborating on an educational campaign to bring awareness to the issue of blue light exposure from digital devices.

This campaign will unfurl over the month of October, kicking off with the launch of bluelightawarenessday.org, the landing page and educational hub for blue light information, articles, videos and more. The campaign itself includes public relations, educational articles and tips, social media materials, email, influencers and charitable donations to school districts across the country.

Media interview opportunities are available with John Ryan, CEO of UnitedHealthcare Vision, Justin Barrett, CEO of Eyesafe, Chris Ahern, CEO of ZAGG and California-based Ophthalmologists Dagny Zhu, M.D. for topics related to screen time, blue light exposure, and potential health risks.

Media Contact:
[email protected]

SOURCE Eyesafe


These press releases may also interest you

at 08:15
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has set the record date for the...

at 08:15
Reprieve Cardiovascular, Inc. (?Reprieve'), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart...

at 08:11
The International Association of Eating Disorder Professionals (iaedptm) 2024 Symposium marked a significant milestone, reflecting growth and renewed commitment within the field of eating disorder treatment. The event showcased an impressive array of...

at 08:10
Kelonia Therapeutics, Inc., a biotech company revolutionizing in vivo gene delivery, announced preclinical data from its lead in vivo CAR-T cell therapeutic candidate KLN-1010 in multiple myeloma that will be highlighted at two upcoming scientific...

at 08:10
bioAffinity Technologies, Inc. shares recent Company news. CyPath® Lung Sales Ramp Up Month over Month Sales of CyPath® Lung, our noninvasive diagnostic test for the early detection of lung cancer, continue to climb, with April sales up 21% over...

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, announced the results of a study examining the motivators and deterrents of clinical trial participation among ethnic minorities. The...



News published on and distributed by: